Shalini Sharp
Director at Iambic Therapeutics.
Raised on Iambic Therapeutics filings
$27.8M
of $50M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 11
- Last filing
- Apr 8, 2026
Company
AI drug design with automated synthesis and testing
- Investors
- 7
- Still open
- $22.2M
Iambic Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Apr 8, 2026 | Equity | $27.8M/ $50M | Form D |
- EquityFiled Apr 8, 2026Form D$27.8M/ $50M
Works with
Thomas MillerChief Executive Officer, Form D signerForm D signerPete OlsonExecutive OfficerKurt von EmsterDirectorR. Jacob VogelsteinDirectorEvan RachlinDirectorFred ManbyExecutive Officer, DirectorJishnu BhattacharjeeDirectorMary TagliaferriDirectorMichael SecoraExecutive OfficerNeil JosephsonExecutive OfficerWilliam RastetterDirector
